Literature DB >> 27514962

Multidrug resistance mediated by co-carriage of extended-spectrum beta-lactamases, AmpC and New Delhi metallo-beta-lactamase-1 genes among carbapenem-resistant Enterobacteriaceae at five Indian medical centres.

A Manoharan1, G S Barla2, R Peter2, M Sugumar2, D Mathai3.   

Abstract

In this study, we evaluated the coexistence of extended-spectrum beta-lactamases (ESBL), AmpC and New Delhi metallo-beta-lactamase-1 (NDM-1) genes among carbapenem-resistant Enterobacteriaceae (CRE) recovered prospectively from patients at multiple sites. The study included 285 CRE strains from 2782 Gram-negative Bacilli collected from multiple centres during 2007-2010, of which 87 were characterised. Standard and reference laboratory methods were used for resistance determination. Detection of blaNDM-1 , blaAmpC , blaTEM , blaSHV and blaCTX-M was done by polymerase chain reaction. High levels of antimicrobial resistance observed among study isolates. Co-carriage of ESBLs, AmpC and NDM-1 was 26.3%. Nosocomial origin among the co-carriage isolates was 64.3%, with 9.2% associated mortality.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27514962     DOI: 10.4103/0255-0857.188350

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  2 in total

1.  Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae: A Menace to Highly Vulnerable Patients.

Authors:  Amarjeet Kumar; Sarita Mohapatra; Sameer Bakhshi; Manoranjan Mahapatra; V Sreenivas; Bimal K Das; Seema Sood; Arti Kapil
Journal:  J Glob Infect Dis       Date:  2018 Oct-Dec

2.  Gut Colonization with Carbapenem-resistant Enterobacteriaceae Adversely Impacts the Outcome in Patients with Hematological Malignancies: Results of A Prospective Surveillance Study.

Authors:  Sarita Rani Jaiswal; Satyanker Gupta; Rekha Saji Kumar; Amit Sherawat; Ashok Rajoreya; Saroj K Dash; Gitali Bhagwati; Suparno Chakrabarti
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-05-01       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.